Company / Inventory
Tandem Diabetes Care Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$128.8M
FY2025
5-year range
$68.6M / $157.9M
FY2021-FY2025
Trend
-13.9%
vs FY2024
Sector context
#69 of 115
Health Care
What the data says
At $129M, Tandem Diabetes Care's inventory ranks #69 of 115 in the Health Care sector. Inventory has fluctuated over the past 10 years, ranging from $20M in FY2018 to $158M in FY2023.
Based on SEC 10-K filings.
$129M in FY2025 with a 5-year CAGR of +15.1%.
Declined from $158M to $129M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +5.0%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Sector benchmark
#69 of 115 in Health CareTop 60% of 115This company $128.8M Sector average $1.4B
▼
-90.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.1%, indicating consistent growth.
- In FY2025, inventory decreased 13.9% year-over-year.
- Ranks #69 out of 115 companies in the Health Care sector.
- Peak inventory was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $128.8M | -13.9% |
| FY2024 | $149.6M | -5.3% |
| FY2023 | $157.9M | +42.1% |
| FY2022 | $111.1M | +62.1% |
| FY2021 | $68.6M | +7.6% |
| FY2020 | $63.7M | +29.8% |
| FY2019 | $49.1M | +146.6% |
| FY2018 | $19.9M | -26.3% |
| FY2017 | $27.0M | +27.4% |
| FY2016 | $21.2M | +20.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026